← Leaderboards
Carla I Falkson
University Of Pretoria
$889,108
Attributed
$3,331,760
Total exposure
8
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $697.8K · FY2006–19$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,331,760 · 8
By mechanism
U10$2,814,360 · 2
UG1$482,879 · 1
M01$34,521 · 5
Top collaborators
- Jennifer De Los Santos5 shared
- Mary-Ann Bjornsti4 shared
- Charles A. Leath4 shared
- Ronald D. Alvarez3 shared
- Paolo Erba3 shared
- Andres Forero3 shared
- Harry Paul Erba2 shared
- Amitkumar N Mehta2 shared
Most similar at University Of Pretoria
Same institution · by research overlap
- Coenraad F Slabber$587,651
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchFundingResearch PersonnelClinical TrialsParticipantCancer PreventionCommunity OutreachClinical Trials Cooperative GroupComprehensive Cancer CenterAchievementAnticancer ResearchAmerican College Of Radiology Imaging NetworkCommunitiesCancer RiskArkansasAlabamaAreaCancer PatientCancer And Leukemia Group BCancer BiologyCancer CareBasic ScienceCancer ControlCancer Health Disparity
Grant awards (13)
NCTN Deep South Research Consortium$482,879
UG1 · FY2019 · CA
NCTN Deep South Research Consortium$436,712
U10 · FY2018 · CA
NCTN Deep South Research Consortium$497,800
U10 · FY2017 · CA
NCTN Deep South Research Consortium$497,800
U10 · FY2016 · CA
NCTN Deep South Research Consortium$497,800
U10 · FY2015 · CA
NCTN Deep South Research Consortium$199,999
U10 · FY2015 · CA
NCTN Deep South Research Consortium$497,800
U10 · FY2014 · CA
E2104 TRIAL OF AVASTIN DD ADRIAMYCIN AND CYTOXAN FOLLOWED BY TAXOL IN LYMPH NODE$12,732
M01 · FY2007 · RR · contact PI
UAB 0461 BEVACIZUMAB TO REVERSE ACQUIRED ESTROGEN INDEPENDENCE IN BREAST CANCER$3,525
M01 · FY2006 · RR · contact PI
High dose interferon vs observation in st. 3-4 melanoma$11,346
M01 · FY2004 · RR
ECOG E4697 Phase III trial of GM-CSF vs peptide$6,088
M01 · FY2004 · RR
Phase III chemoprevention trial with selenium in NSCLC$830
M01 · FY2004 · RR
EASTERN COOPERATIVE ONCOLOGY GROUP$186,449
U10 · FY2000 · CA